Cardiovascular Disease is one of the leading causes of death, and a new treatment is seeking FDA approval. You can become part of the exclusive group that gets access to this treatment through our Cardiovascular Disease Clinical Study in LA. If you are between the ages of 40 and 79, you can sign up to become a participant today. Keep reading to learn more about the Cardiovascular Disease Clinical Study in LA and how to get started as a participant.
What is Cardiovascular Disease?
Cardiovascular diseases (CVDs) are a group of disorders of the heart and blood vessels. They include:
- coronary heart disease – a disease of the blood vessels supplying the heart muscle;
- cerebrovascular disease – a disease of the blood vessels supplying the brain;
- peripheral arterial disease – a disease of blood vessels supplying the arms and legs;
- rheumatic heart disease – damage to the heart muscle and heart valves from rheumatic fever, caused by streptococcal bacteria;
- congenital heart disease – birth defects that affect the normal development and functioning of the heart caused by malformations of the heart structure from birth; and
- deep vein thrombosis and pulmonary embolism – blood clots in the leg veins, which can dislodge and move to the heart and lungs.
Facts surrounding Cardiovascular disease include:
- Cardiovascular diseases (CVDs) are the leading cause of death globally.
- An estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke.
- Over three-quarters of CVD deaths take place in low- and middle-income countries.
- Out of the 17 million premature deaths (under the age of 70) due to noncommunicable diseases in 2019, 38% were caused by CVDs.
Do I Qualify for the Cardiovascular Disease Clinical Study in LA?
If you are between the ages of 40 and 79, you can sign up for our Cardiovascular Disease Clinical Study in LA. All you have to do is click here to fill out a short contact information form. Our team will contact you to conduct the initial screening call and potentially invite you to our office for a complimentary medical exam to see if you meet the study guidelines. If you do, you will be asked to join. It’s simple!
Is The Cardiovascular Disease Clinical Study in LA Safe?
Yes! This professional clinical study is a short-term trial in which you will be given a promising new medication seeking FDA approval. Participants in the study are placed in different groups and monitored for safety and treatment throughout the process.
This clinical research study is a Phase 2 study, which means the Phase 1 study was very promising, and the FDA approved the study to move to Phase 2. Phase 1 study included human participants and saw limited adverse reaction issues.
This study also includes the following safety measures:
- Meets all industry safety guidelines
- Governed & monitored by a central ethics committee
- FDA-governed
- HIPAA-compliant
- Full confidentiality
- Guaranteed compensation
For more information on our clinic or to see other clinical trials we are currently enrolling participants in, visit us at clinicalresearchla.com!
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.clinicalresearchla.com/cardiovascular-disease-clinical-study-in-la/
